Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 664267
                    [Title] => Novartis drug vs diabetic macular edema gets FDA okay
                    [Summary] => 
The Philippine Food and Drug Administration (FDA) has granted research-based Swiss health care company Novartis a new indication for ranibizumab to treat vision loss due to diabetic macular edema (DME), one of the most feared diabetes complications that can cause disabling vision loss.
                    [DatePublished] => 2011-03-10 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

DIABETIC RETINOPATHY CLINICAL RESEARCH NETWORK

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 664267
                    [Title] => Novartis drug vs diabetic macular edema gets FDA okay
                    [Summary] => 
The Philippine Food and Drug Administration (FDA) has granted research-based Swiss health care company Novartis a new indication for ranibizumab to treat vision loss due to diabetic macular edema (DME), one of the most feared diabetes complications that can cause disabling vision loss.
                    [DatePublished] => 2011-03-10 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Novartis drug vs diabetic macular edema gets FDA okay

March 10, 2011 - 12:00am

The Philippine Food and Drug Administration (FDA) has granted research-based Swiss health care company Novartis a new indication for ranibizumab to treat vision loss due to diabetic macular edema (DME), one of the...

Science and Environment